射血分数保留的急性冠状动脉综合征后β受体阻滞剂的作用 - Suppr | 超能文献

Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction.

作者信息

Singh Sahib, Bliden Kevin, Tantry Udaya S, Gurbel Paul A, Kanjwal Mohammed Y, Lundgren Scott W

机构信息

Department of Medicine.

Sinai Center for Thrombosis Research.

出版信息

Am J Cardiol. 2025 Jan 15;235:73-75. doi: 10.1016/j.amjcard.2024.10.027. Epub 2024 Oct 28.

DOI:10.1016/j.amjcard.2024.10.027

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Role of Beta Blockers After Acute Coronary Syndrome With Preserved Ejection Fraction.射血分数保留的急性冠状动脉综合征后β受体阻滞剂的作用

Am J Cardiol. 2025 Jan 15;235:73-75. doi: 10.1016/j.amjcard.2024.10.027. Epub 2024 Oct 28.

2

Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?急性冠脉综合征伴收缩功能保留患者使用β受体阻滞剂的预后获益。如今仍具相关性吗？

Rev Esp Cardiol (Engl Ed). 2015 Jul;68(7):585-91. doi: 10.1016/j.rec.2014.07.028. Epub 2014 Dec 13.

3

Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.β受体阻滞剂治疗经皮血运重建术治疗的冠心病患者降低死亡率：调整结果的荟萃分析。

J Cardiovasc Med (Hagerstown). 2018 Jul;19(7):337-343. doi: 10.2459/JCM.0000000000000662.

4

Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34).急性冠状动脉综合征后左心室射血分数降低的患者未达到二级预防药物的目标剂量（ANZACS-QI 34）。

Heart Lung Circ. 2020 Sep;29(9):1386-1396. doi: 10.1016/j.hlc.2020.03.013. Epub 2020 Apr 13.

5

β-Blockers in myocardial infarction and coronary artery disease with a preserved ejection fraction: recommendations, mechanisms, and concerns.射血分数保留的心肌梗死和冠状动脉疾病中的β受体阻滞剂：推荐意见、作用机制及相关问题

Coron Artery Dis. 2018 May;29(3):262-270. doi: 10.1097/MCA.0000000000000610.

6

Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study.β受体阻滞剂用于急性冠状动脉综合征射血分数中值：一项全国性回顾性研究。

Eur Heart J Acute Cardiovasc Care. 2019 Oct;8(7):599-605. doi: 10.1177/2048872619827476. Epub 2019 Feb 4.

7

Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.急性冠状动脉综合征后左心室射血分数正常或轻度降低时停用β受体阻滞剂的安全性：来自真实世界队列的目标试验模拟

Eur J Prev Cardiol. 2024 Oct 26. doi: 10.1093/eurjpc/zwae346.

8

Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry.β 受体阻滞剂与射血分数保留心力衰竭结局的相关性：来自瑞典心力衰竭注册研究的最新见解。

J Card Fail. 2021 Nov;27(11):1165-1174. doi: 10.1016/j.cardfail.2021.04.015. Epub 2021 May 8.

9

Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.β受体阻滞剂对急性心肌梗死后射血分数保留患者左心室重构的影响。

Int J Cardiol. 2016 Oct 15;221:765-9. doi: 10.1016/j.ijcard.2016.07.123. Epub 2016 Jul 9.

10

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。

Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.

引用本文的文献

1

The Value of Clinical Variables and the Potential of Longitudinal Ultrasound Carotid Plaque Assessment in Major Adverse Cardiovascular Event Prediction After Uncomplicated Acute Coronary Syndrome.临床变量的价值及纵向超声评估颈动脉斑块在单纯急性冠状动脉综合征后主要不良心血管事件预测中的潜力

Life (Basel). 2025 Mar 9;15(3):431. doi: 10.3390/life15030431.